FDA Approved: FIRAZYR — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for FIRAZYR (icatibant acetate) submitted by Takeda Pharmaceuticals America, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Firazyr (icatibant)

Snippet

SUPPL AP for FIRAZYR (ICATIBANT ACETATE)